A potential target for ovarian cancer is the marker human epidermal growth factor receptor-2 (HER2), a member of the epidermal growth factor receptor (EGFR) family of transmembrane receptor tyrosine kinases. This evidence concerns the gene EGFR and ovarian cancer.